Correction to: Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR+ Breast Cancer—An NCDB Analysis (2004–2016) (Annals of Surgical Oncology, (2021), 28, 13, (8651-8662), 10.1245/s10434-021-10287-5)

Macy M. Goldbach, Laura Burkbauer, Tina Bharani, Austin D. Williams, Luke Keele, Jami Rothman, Rachel Jankowitz, Julia C. Tchou

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

The electronic supplementary material for this article has been updated.

Original languageEnglish
Pages (from-to)888
Number of pages1
JournalAnnals of Surgical Oncology
Volume28
DOIs
StatePublished - Dec 2021
Externally publishedYes

Fingerprint

Dive into the research topics of 'Correction to: Effectiveness of a Short Duration of Neoadjuvant Endocrine Therapy in Patients with HR+ Breast Cancer—An NCDB Analysis (2004–2016) (Annals of Surgical Oncology, (2021), 28, 13, (8651-8662), 10.1245/s10434-021-10287-5)'. Together they form a unique fingerprint.

Cite this